Kate Riney

501 Stanley St
South Brisbane, QLD 4101, Australia

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 55 publications

Changes in effectiveness and safety in patients with Lennox-Gastaut syndrome transitioning from the fenfluramine randomized controlled trial to open-label extension study.

Changes in effectiveness and safety in patients with Lennox-Gastaut syndrome transitioning from the fenfluramine randomized controlled trial to open-label extension study.

Journal: Epilepsia open

Published: April 01, 2026

KCNQ2 neonatal epilepsy: Impact of prompt diagnosis and treatment, and early predictors of outcome severity.

KCNQ2 neonatal epilepsy: Impact of prompt diagnosis and treatment, and early predictors of outcome severity.

Journal: Epilepsia open

Published: October 27, 2025

A global perspective on transitioning from pediatric to adult care in epilepsy.

A global perspective on transitioning from pediatric to adult care in epilepsy.

Journal: Epilepsia

Published: August 05, 2025

Final analysis from an open-label extension study of fenfluramine for the treatment of seizures in Lennox-Gastaut syndrome: long-term impact on patients and caregivers.

Final analysis from an open-label extension study of fenfluramine for the treatment of seizures in Lennox-Gastaut syndrome: long-term impact on patients and caregivers.

Journal: Epilepsy & behavior : E&B

Published: July 18, 2025

Mechanisms of SCN2A loss of function do not predict presence or phenotype of epilepsy.

Mechanisms of SCN2A loss of function do not predict presence or phenotype of epilepsy.

Journal: Epilepsia

Published: June 17, 2025

Availability and affordability of cannabinoids for epilepsy treatment across different geographic settings-A survey from the ILAE Plant-Based Therapy Task Force.

Availability and affordability of cannabinoids for epilepsy treatment across different geographic settings-A survey from the ILAE Plant-Based Therapy Task Force.

Journal: Epilepsia

Published: May 11, 2025

Ketogenic drug tricaprilin (CER-0001) for the treatment of refractory infantile epileptic spasms: a phase 1/2a study.

Ketogenic drug tricaprilin (CER-0001) for the treatment of refractory infantile epileptic spasms: a phase 1/2a study.

Journal: Frontiers in pediatrics

Published: February 11, 2025

Epilepsy syndromes classification.

Epilepsy syndromes classification.

Journal: Epilepsia open

Published: January 10, 2025

Vigabatrin-associated brain magnetic resonance imaging abnormalities and clinical symptoms in infants with tuberous sclerosis complex.

Vigabatrin-associated brain magnetic resonance imaging abnormalities and clinical symptoms in infants with tuberous sclerosis complex.

Journal: Epilepsia

Published: August 16, 2024

Impaired GABAergic regulation and developmental immaturity in interneurons derived from the medial ganglionic eminence in the tuberous sclerosis complex.

Impaired GABAergic regulation and developmental immaturity in interneurons derived from the medial ganglionic eminence in the tuberous sclerosis complex.

Journal: Acta neuropathologica

Published: March 14, 2024

Vitamin D prophylaxis in persons with epilepsy?

Vitamin D prophylaxis in persons with epilepsy?

Journal: Epilepsia

Published: February 27, 2024

Have epilepsy outcomes changed for children with tuberous sclerosis complex in Queensland, Australia?

Have epilepsy outcomes changed for children with tuberous sclerosis complex in Queensland, Australia?

Journal: Epilepsia

Published: December 17, 2023

Showing 1-12 of 55

Last Updated: 09/26/2026